Filaggrin related antibodies among the aged

Annals of the Rheumatic Diseases

Volumn 62, Issue 3, 2003, Pages 261-263

  Palosuo, T ^a   Tilvis, R ^b   Strandberg, T ^b   Aho, K ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; FILAGGRIN; PROTEIN ANTIBODY; RHEUMATOID FACTOR;

AGED; AGING; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CITRULLINE; HUMANS; IMMUNOGLOBULIN G; INTERMEDIATE FILAMENT PROTEINS; PEPTIDES, CYCLIC; SENSITIVITY AND SPECIFICITY;

EID: 0037369432     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.3.261     Document Type: Article

References (16)

1. Aho K, Palosuo T. Can outcome of early synovitis be predicted by serological tests? Clin Rheumatol 2002;21:97-102.
2. Kyburz D, Carson DA. Rheumatoid factor. In: Firestein GS, Panyay GS, Wollheim FA, eds. Rheumatoid arthritis. Oxford: Oxford University Press, 2000:179-87.
3. Bridges SL. Rheumatoid factor. In: Koopman WJ, ed. Arthritis and allied conditions. 14th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:1223-44.
4. Kaipiainen-Seppänen O, Aho K, Isomäki H, Laakso M. Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990. Clin Exp Rheumatol 1996;14:537-42.
5. Imaraka T, Schichikawa K, Inoue K, Shimaoka Y, Takenaka Y, Wakitani S. Increase in age at onset of rheumatoid arthritis in Japan over a 30 year period. Ann Rheum Dis 1997;56:313-16.
6. Youinou P, Serre G. The antiperinuclear factor and antikeratin antibody systems. Int Arch Allergy Immunol 1995;107:508-18.
7. Schellekens GA, Visser H, de Jang BAW, van den Hogen FHJ, Hazes JMW, Breedweld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63.
8. Tilvis RS, Hakala S-M, Valvanne J, Erkinjuntti T. Postural hypotension and dizziness in a general aged population: a four-year follow-up of Helsinki Aging Study. J Am Geriatr Soc 1996;44:809-14.
9. Tilvis RS, Strandberg TE, Juva K. Lipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc 1998;46:712-15.
10. Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, et al. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol 1998;115:294-302.
11. Nykänen M, Palosuo T, Aho K, Sahi T, von Essen R. Improved immunoturbidimetric method for rheumatoid factor testing. J Clin Pathol 1993;46:1065-6.
12. Mikkelsen WM, Dodge HJ, Duff JF, Kato H. Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959-60. J Chron Dis 1967;20:351-69.
13. Aho K, Tuomi T, Heliövaara M, Palosuo T. Rheumatoid factors and rheumatoid arthritis. Scand J Rheumatol Suppl 1988;18(suppl 74):41-4.
14. van Schaardenburg D, Lagaay AM, Otten HG, Breedveld FC. The relation between class-specific serum rheumatoid factors and age in the general population. Br J Rheumatol 1993;32:546-9.
15. Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournié B, Cantagrel A, et al. Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis 2001;60:882-7.
16. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236-43.